CAMCD is pleased to be collaborator on the CANARY study.
This nation-wide study is open to patients with any medical condition who access cannabis under the MMAR, MMPR or neither government program. It is also open to patients who do not currently use cannabis.
The CANARY Study is examining the impact of regulatory changes on patient access to cannabis for medical purposes.
Participation in the CANARY Study involves the completion of 3 online surveys over the next year, as well as interviews for a small subset of participants.
The CANARY Study is lead by researchers at the University of British Columbia in collaboration with the British Columbia Ministry of Health, the Canadian Consortium for the Investigation of Cannabinoids and the Canadian AIDS Society. Other affiliated organizations include: Canadian Medical Association, Canadian Cancer Society, British Columbia Cancer Agency, Canadian Association of Medical Cannabis Dispensaries, Action Atlantic, Chronic Pain Association of Canada, and Canadian Pain Coalition.
More information and a link to the survey can be found at http://canarystudy.ca.
Please pass on to anyone who you think may be interested in participating.